Bausch Health Companies | VRX - Equity Capital And Reserves

Stock Price
8.20
Daily Change
-0.17 -2.03%
Monthly
5.26%
Yearly
-25.72%
Q1 Forecast
8.16

Bausch Health Companies reported $-554M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Amgen USD 8.66B 961M Dec/2025
ANI Pharmaceuticals USD 505.82M 69.06M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bausch Health Companies USD -554M 910M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Pacira USD 727.21M 30.55M Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025